India Next Generation Sequencing Market Outlook to 2030

India Next Generation Sequencing Market Overview

• The India Next Generation Sequencing Market is valued at USD 720 million and is driven by rising investments in personalized medicine, genomic research, and the adoption of NGS technologies across various medical and non-medical applications. The India Next Generation Sequencing (NGS) market is poised for rapid growth, driven by increasing demand for advanced genetic analysis technologies in sectors such as healthcare, pharmaceuticals, and research.
• Major hubs for NGS technology development in India include cities like Bengaluru, Hyderabad, and Pune, which host prominent research institutions and biotechnology companies. These cities have attracted significant investments from global pharmaceutical giants and academic institutions, contributing to India's position as a growing center for genomic and biotech research. The collaboration between academia and the private sector is a key factor boosting the NGS market.
• The Indian government's initiatives to improve healthcare infrastructure and promote the adoption of precision medicine, along with the increasing awareness of genetic disorders and cancer research, have accelerated the use of NGS technologies. Furthermore, the COVID-19 pandemic has highlighted the importance of genomic sequencing for tracking and understanding virus mutations, further stimulating market growth.

India Next Generation Sequencing Market Segmentation

• By Product Type: The market is segmented into consumables, platforms, and services. The consumables segment holds the largest share due to the continuous demand for reagents, kits, and other consumables required in NGS workflows. Platforms, including sequencers and associated hardware, are gaining traction as technological advancements lead to the development of faster and more accurate sequencing systems. Services, which include bioinformatics, data analysis, and storage solutions, are also expanding due to the need for efficient management of large-scale genomic data.

• By Application: The market is segmented by application into clinical diagnostics, drug discovery, agriculture & animal research, and others. Clinical diagnostics holds the largest share, driven by the growing use of NGS in cancer diagnostics, hereditary disease screening, and infectious disease research. Drug discovery is also a significant application, as pharmaceutical companies utilize NGS to identify novel drug targets and biomarkers. Agriculture & animal research applications are gaining attention due to the role of NGS in improving crop yield and livestock breeding through genomic analysis.

India Next Generation Sequencing Market Competitive Landscape

The India NGS market is highly competitive, with a mix of domestic and international players driving innovation and adoption. Key companies such as Illumina, Thermo Fisher Scientific, Agilent Technologies, BGI Group, and Oxford Nanopore Technologies are leading the market through strategic partnerships, advancements in sequencing technologies, and expansion of R&D capabilities.

India Next Generation Sequencing Market Analysis

Growth Drivers

• Growing Adoption of Personalized Medicine: The adoption of personalized medicine in India is rapidly increasing as healthcare providers look for more targeted treatments based on individual genetic profiles. In 2023, India saw a sharp rise in healthcare expenditure, which includes investments in advanced medical technologies like NGS. Personalized medicine has gained significant attention due to its role in oncology, with 1.46 million cancer cases being recorded in India, driving the demand for NGS to aid in early detection and customized treatment plans. The Indian government has increased funding for genomic studies, allocating $120 million toward precision medicine initiatives.
• Increasing Demand for Genomic Research and Precision Medicine: Genomic research in India is experiencing substantial growth, with an increasing number of research institutes focusing on precision medicine. The establishment of the Genome India Project by the government aims to map the genetic diversity of the country. This project supports NGS by expanding research capabilities, enhancing disease prevention, and developing new drugs. Furthermore, India spends over USD 470 million annually on biomedical research, highlighting the expanding interest in genomic research, positioning NGS as an essential tool in this growth.
• Expanding Use of NGS in Agriculture and Animal Research: India’s agriculture and animal research sector is increasingly adopting NGS for genetic studies, with a focus on improving crop yields and livestock. As of 2024, India is home to over 250 agricultural research institutes. NGS is applied in studies concerning drought-resistant crops and livestock disease mitigation, with the government investing nearly USD 15 million annually in agricultural genomics. This aligns with India’s agricultural GDP of $480 billion, reflecting the growing relevance of NGS technology in enhancing the country's agricultural productivity and resilience to climate change.

Market Challenges

• Limited Access to Trained Workforce in Bioinformatics: India faces a shortage of bioinformatics professionals capable of handling the complex data generated by NGS technologies. In 2024, the country had only 3,500 professionals with expertise in bioinformatics, compared to the growing demand from over 200 genomic research centers. Although universities are expanding bioinformatics programs, the current supply of trained professionals is insufficient, which poses a challenge in fully leveraging the potential of NGS technologies. This gap in the workforce is a significant hurdle to the efficient use of genomic data in medical and agricultural research.
• Complex Regulatory Landscape in Genomic Data Handling: India’s regulatory framework for genomic data handling is fragmented and complicated. In 2023, India introduced a draft policy for data privacy and storage for genomic data, but its implementation remains unclear. Genomic data often falls under multiple regulatory bodies, including the Ministry of Health and Family Welfare and the Information Technology Act, creating regulatory hurdles. Lack of clarity on cross-border data transfer and privacy protections slows down research and collaboration with international institutions, affecting the widespread application of NGS in both healthcare and agriculture.

India Next Generation Sequencing Market Future Outlook

The India NGS market is expected to experience substantial growth through 2028, driven by advancements in genomic research, increasing adoption of personalized medicine, and expanding applications in agriculture and healthcare. Innovations in NGS technologies, particularly in sequencing speed, accuracy, and affordability, will further enhance the market's potential in both clinical and non-clinical applications.

Future Market Opportunities

• Development of Low-Cost NGS Platforms: The development of more affordable NGS platforms presents a significant opportunity for the Indian market. Currently, several Indian biotech firms are working on producing NGS platforms at lower costs, which could bring prices down to as low as $50,000 per unit. With government support, such as the 'Make in India' initiative, and foreign investments reaching millions in biotechnology in 2024, the local production of these platforms is set to boost accessibility for research institutions and hospitals across the country.
• Expansion into Rural and Underserved Areas: There is significant potential for NGS applications in rural and underserved areas of India, especially in healthcare and agriculture. The Indian government has announced initiative worth millions to support rural healthcare infrastructure, which includes integrating advanced diagnostics like NGS. In agriculture, rural genomics programs are being launched to improve crop yields and livestock health. This expansion opens new avenues for NGS adoption, not only in urban centers but also in rural parts of the country, where agriculture forms the backbone of the economy.